0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Computational Immunology Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-26F2205
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Computational Immunology Market Insights and Forecast to 2028
BUY CHAPTERS

Global Computational Immunology Market Research Report 2024

Code: QYRE-Auto-26F2205
Report
January 2024
Pages:99
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Computational Immunology Market

Computational Immunology is a field of science that encompasses high-throughput genomic and bioinformatics approaches to immunology. The field's main aim is to convert immunological data into computational problems, solve these problems using mathematical and computational approaches and then convert these results into immunologically meaningful interpretations.
The global Computational Immunology market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Computational Immunology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Computational Immunology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Computational Immunology in Allergy Prediction Databases is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Computational Immunology include EpiVax, Novozymes Biopharma, ioGenetics, International Society of Vaccines, IMGT, Dassault Systemes, Certara, Chemical Computing Group and Compugen, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Computational Immunology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Computational Immunology.

Report Scope

The Computational Immunology market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Computational Immunology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Computational Immunology companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Computational Immunology Market Report

Report Metric Details
Report Name Computational Immunology Market
Segment by Type
  • Cancer Diagnosis & Therapy
  • Reverse Vaccinology
  • Immune System Modeling
Segment by Application
  • Allergy Prediction Databases
  • Analysis Resource Database
  • International Immunogenetics System
  • The Ontology of Immune Epitopes
  • Immune Epitope Database
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company EpiVax, Novozymes Biopharma, ioGenetics, International Society of Vaccines, IMGT, Dassault Systemes, Certara, Chemical Computing Group, Compugen, Genedata AG, Insilico Biotechnology AG, Leadscope Inc, Nimbus Discovery, Strand Life Sciences, Schrodinger, Simulation Plus, Rosa & Co
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Computational Immunology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Computational Immunology Market report?

Ans: The main players in the Computational Immunology Market are EpiVax, Novozymes Biopharma, ioGenetics, International Society of Vaccines, IMGT, Dassault Systemes, Certara, Chemical Computing Group, Compugen, Genedata AG, Insilico Biotechnology AG, Leadscope Inc, Nimbus Discovery, Strand Life Sciences, Schrodinger, Simulation Plus, Rosa & Co

What are the Application segmentation covered in the Computational Immunology Market report?

Ans: The Applications covered in the Computational Immunology Market report are Allergy Prediction Databases, Analysis Resource Database, International Immunogenetics System, The Ontology of Immune Epitopes, Immune Epitope Database

What are the Type segmentation covered in the Computational Immunology Market report?

Ans: The Types covered in the Computational Immunology Market report are Cancer Diagnosis & Therapy, Reverse Vaccinology, Immune System Modeling

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Computational Immunology Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Cancer Diagnosis & Therapy
1.2.3 Reverse Vaccinology
1.2.4 Immune System Modeling
1.3 Market by Application
1.3.1 Global Computational Immunology Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Allergy Prediction Databases
1.3.3 Analysis Resource Database
1.3.4 International Immunogenetics System
1.3.5 The Ontology of Immune Epitopes
1.3.6 Immune Epitope Database
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Computational Immunology Market Perspective (2019-2030)
2.2 Computational Immunology Growth Trends by Region
2.2.1 Global Computational Immunology Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Computational Immunology Historic Market Size by Region (2019-2024)
2.2.3 Computational Immunology Forecasted Market Size by Region (2025-2030)
2.3 Computational Immunology Market Dynamics
2.3.1 Computational Immunology Industry Trends
2.3.2 Computational Immunology Market Drivers
2.3.3 Computational Immunology Market Challenges
2.3.4 Computational Immunology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Computational Immunology Players by Revenue
3.1.1 Global Top Computational Immunology Players by Revenue (2019-2024)
3.1.2 Global Computational Immunology Revenue Market Share by Players (2019-2024)
3.2 Global Computational Immunology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Computational Immunology Revenue
3.4 Global Computational Immunology Market Concentration Ratio
3.4.1 Global Computational Immunology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Computational Immunology Revenue in 2023
3.5 Computational Immunology Key Players Head office and Area Served
3.6 Key Players Computational Immunology Product Solution and Service
3.7 Date of Enter into Computational Immunology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Computational Immunology Breakdown Data by Type
4.1 Global Computational Immunology Historic Market Size by Type (2019-2024)
4.2 Global Computational Immunology Forecasted Market Size by Type (2025-2030)
5 Computational Immunology Breakdown Data by Application
5.1 Global Computational Immunology Historic Market Size by Application (2019-2024)
5.2 Global Computational Immunology Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Computational Immunology Market Size (2019-2030)
6.2 North America Computational Immunology Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Computational Immunology Market Size by Country (2019-2024)
6.4 North America Computational Immunology Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Computational Immunology Market Size (2019-2030)
7.2 Europe Computational Immunology Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Computational Immunology Market Size by Country (2019-2024)
7.4 Europe Computational Immunology Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Computational Immunology Market Size (2019-2030)
8.2 Asia-Pacific Computational Immunology Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Computational Immunology Market Size by Region (2019-2024)
8.4 Asia-Pacific Computational Immunology Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Computational Immunology Market Size (2019-2030)
9.2 Latin America Computational Immunology Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Computational Immunology Market Size by Country (2019-2024)
9.4 Latin America Computational Immunology Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Computational Immunology Market Size (2019-2030)
10.2 Middle East & Africa Computational Immunology Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Computational Immunology Market Size by Country (2019-2024)
10.4 Middle East & Africa Computational Immunology Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 EpiVax
11.1.1 EpiVax Company Detail
11.1.2 EpiVax Business Overview
11.1.3 EpiVax Computational Immunology Introduction
11.1.4 EpiVax Revenue in Computational Immunology Business (2019-2024)
11.1.5 EpiVax Recent Development
11.2 Novozymes Biopharma
11.2.1 Novozymes Biopharma Company Detail
11.2.2 Novozymes Biopharma Business Overview
11.2.3 Novozymes Biopharma Computational Immunology Introduction
11.2.4 Novozymes Biopharma Revenue in Computational Immunology Business (2019-2024)
11.2.5 Novozymes Biopharma Recent Development
11.3 ioGenetics
11.3.1 ioGenetics Company Detail
11.3.2 ioGenetics Business Overview
11.3.3 ioGenetics Computational Immunology Introduction
11.3.4 ioGenetics Revenue in Computational Immunology Business (2019-2024)
11.3.5 ioGenetics Recent Development
11.4 International Society of Vaccines
11.4.1 International Society of Vaccines Company Detail
11.4.2 International Society of Vaccines Business Overview
11.4.3 International Society of Vaccines Computational Immunology Introduction
11.4.4 International Society of Vaccines Revenue in Computational Immunology Business (2019-2024)
11.4.5 International Society of Vaccines Recent Development
11.5 IMGT
11.5.1 IMGT Company Detail
11.5.2 IMGT Business Overview
11.5.3 IMGT Computational Immunology Introduction
11.5.4 IMGT Revenue in Computational Immunology Business (2019-2024)
11.5.5 IMGT Recent Development
11.6 Dassault Systemes
11.6.1 Dassault Systemes Company Detail
11.6.2 Dassault Systemes Business Overview
11.6.3 Dassault Systemes Computational Immunology Introduction
11.6.4 Dassault Systemes Revenue in Computational Immunology Business (2019-2024)
11.6.5 Dassault Systemes Recent Development
11.7 Certara
11.7.1 Certara Company Detail
11.7.2 Certara Business Overview
11.7.3 Certara Computational Immunology Introduction
11.7.4 Certara Revenue in Computational Immunology Business (2019-2024)
11.7.5 Certara Recent Development
11.8 Chemical Computing Group
11.8.1 Chemical Computing Group Company Detail
11.8.2 Chemical Computing Group Business Overview
11.8.3 Chemical Computing Group Computational Immunology Introduction
11.8.4 Chemical Computing Group Revenue in Computational Immunology Business (2019-2024)
11.8.5 Chemical Computing Group Recent Development
11.9 Compugen
11.9.1 Compugen Company Detail
11.9.2 Compugen Business Overview
11.9.3 Compugen Computational Immunology Introduction
11.9.4 Compugen Revenue in Computational Immunology Business (2019-2024)
11.9.5 Compugen Recent Development
11.10 Genedata AG
11.10.1 Genedata AG Company Detail
11.10.2 Genedata AG Business Overview
11.10.3 Genedata AG Computational Immunology Introduction
11.10.4 Genedata AG Revenue in Computational Immunology Business (2019-2024)
11.10.5 Genedata AG Recent Development
11.11 Insilico Biotechnology AG
11.11.1 Insilico Biotechnology AG Company Detail
11.11.2 Insilico Biotechnology AG Business Overview
11.11.3 Insilico Biotechnology AG Computational Immunology Introduction
11.11.4 Insilico Biotechnology AG Revenue in Computational Immunology Business (2019-2024)
11.11.5 Insilico Biotechnology AG Recent Development
11.12 Leadscope Inc
11.12.1 Leadscope Inc Company Detail
11.12.2 Leadscope Inc Business Overview
11.12.3 Leadscope Inc Computational Immunology Introduction
11.12.4 Leadscope Inc Revenue in Computational Immunology Business (2019-2024)
11.12.5 Leadscope Inc Recent Development
11.13 Nimbus Discovery
11.13.1 Nimbus Discovery Company Detail
11.13.2 Nimbus Discovery Business Overview
11.13.3 Nimbus Discovery Computational Immunology Introduction
11.13.4 Nimbus Discovery Revenue in Computational Immunology Business (2019-2024)
11.13.5 Nimbus Discovery Recent Development
11.14 Strand Life Sciences
11.14.1 Strand Life Sciences Company Detail
11.14.2 Strand Life Sciences Business Overview
11.14.3 Strand Life Sciences Computational Immunology Introduction
11.14.4 Strand Life Sciences Revenue in Computational Immunology Business (2019-2024)
11.14.5 Strand Life Sciences Recent Development
11.15 Schrodinger
11.15.1 Schrodinger Company Detail
11.15.2 Schrodinger Business Overview
11.15.3 Schrodinger Computational Immunology Introduction
11.15.4 Schrodinger Revenue in Computational Immunology Business (2019-2024)
11.15.5 Schrodinger Recent Development
11.16 Simulation Plus
11.16.1 Simulation Plus Company Detail
11.16.2 Simulation Plus Business Overview
11.16.3 Simulation Plus Computational Immunology Introduction
11.16.4 Simulation Plus Revenue in Computational Immunology Business (2019-2024)
11.16.5 Simulation Plus Recent Development
11.17 Rosa & Co
11.17.1 Rosa & Co Company Detail
11.17.2 Rosa & Co Business Overview
11.17.3 Rosa & Co Computational Immunology Introduction
11.17.4 Rosa & Co Revenue in Computational Immunology Business (2019-2024)
11.17.5 Rosa & Co Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Computational Immunology Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Cancer Diagnosis & Therapy
    Table 3. Key Players of Reverse Vaccinology
    Table 4. Key Players of Immune System Modeling
    Table 5. Global Computational Immunology Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Computational Immunology Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Computational Immunology Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Computational Immunology Market Share by Region (2019-2024)
    Table 9. Global Computational Immunology Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Computational Immunology Market Share by Region (2025-2030)
    Table 11. Computational Immunology Market Trends
    Table 12. Computational Immunology Market Drivers
    Table 13. Computational Immunology Market Challenges
    Table 14. Computational Immunology Market Restraints
    Table 15. Global Computational Immunology Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Computational Immunology Market Share by Players (2019-2024)
    Table 17. Global Top Computational Immunology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Computational Immunology as of 2023)
    Table 18. Ranking of Global Top Computational Immunology Companies by Revenue (US$ Million) in 2023
    Table 19. Global 5 Largest Players Market Share by Computational Immunology Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Computational Immunology Product Solution and Service
    Table 22. Date of Enter into Computational Immunology Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Computational Immunology Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Computational Immunology Revenue Market Share by Type (2019-2024)
    Table 26. Global Computational Immunology Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Computational Immunology Revenue Market Share by Type (2025-2030)
    Table 28. Global Computational Immunology Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Computational Immunology Revenue Market Share by Application (2019-2024)
    Table 30. Global Computational Immunology Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Computational Immunology Revenue Market Share by Application (2025-2030)
    Table 32. North America Computational Immunology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 33. North America Computational Immunology Market Size by Country (2019-2024) & (US$ Million)
    Table 34. North America Computational Immunology Market Size by Country (2025-2030) & (US$ Million)
    Table 35. Europe Computational Immunology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. Europe Computational Immunology Market Size by Country (2019-2024) & (US$ Million)
    Table 37. Europe Computational Immunology Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Asia-Pacific Computational Immunology Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 39. Asia-Pacific Computational Immunology Market Size by Region (2019-2024) & (US$ Million)
    Table 40. Asia-Pacific Computational Immunology Market Size by Region (2025-2030) & (US$ Million)
    Table 41. Latin America Computational Immunology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 42. Latin America Computational Immunology Market Size by Country (2019-2024) & (US$ Million)
    Table 43. Latin America Computational Immunology Market Size by Country (2025-2030) & (US$ Million)
    Table 44. Middle East & Africa Computational Immunology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Middle East & Africa Computational Immunology Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Middle East & Africa Computational Immunology Market Size by Country (2025-2030) & (US$ Million)
    Table 47. EpiVax Company Detail
    Table 48. EpiVax Business Overview
    Table 49. EpiVax Computational Immunology Product
    Table 50. EpiVax Revenue in Computational Immunology Business (2019-2024) & (US$ Million)
    Table 51. EpiVax Recent Development
    Table 52. Novozymes Biopharma Company Detail
    Table 53. Novozymes Biopharma Business Overview
    Table 54. Novozymes Biopharma Computational Immunology Product
    Table 55. Novozymes Biopharma Revenue in Computational Immunology Business (2019-2024) & (US$ Million)
    Table 56. Novozymes Biopharma Recent Development
    Table 57. ioGenetics Company Detail
    Table 58. ioGenetics Business Overview
    Table 59. ioGenetics Computational Immunology Product
    Table 60. ioGenetics Revenue in Computational Immunology Business (2019-2024) & (US$ Million)
    Table 61. ioGenetics Recent Development
    Table 62. International Society of Vaccines Company Detail
    Table 63. International Society of Vaccines Business Overview
    Table 64. International Society of Vaccines Computational Immunology Product
    Table 65. International Society of Vaccines Revenue in Computational Immunology Business (2019-2024) & (US$ Million)
    Table 66. International Society of Vaccines Recent Development
    Table 67. IMGT Company Detail
    Table 68. IMGT Business Overview
    Table 69. IMGT Computational Immunology Product
    Table 70. IMGT Revenue in Computational Immunology Business (2019-2024) & (US$ Million)
    Table 71. IMGT Recent Development
    Table 72. Dassault Systemes Company Detail
    Table 73. Dassault Systemes Business Overview
    Table 74. Dassault Systemes Computational Immunology Product
    Table 75. Dassault Systemes Revenue in Computational Immunology Business (2019-2024) & (US$ Million)
    Table 76. Dassault Systemes Recent Development
    Table 77. Certara Company Detail
    Table 78. Certara Business Overview
    Table 79. Certara Computational Immunology Product
    Table 80. Certara Revenue in Computational Immunology Business (2019-2024) & (US$ Million)
    Table 81. Certara Recent Development
    Table 82. Chemical Computing Group Company Detail
    Table 83. Chemical Computing Group Business Overview
    Table 84. Chemical Computing Group Computational Immunology Product
    Table 85. Chemical Computing Group Revenue in Computational Immunology Business (2019-2024) & (US$ Million)
    Table 86. Chemical Computing Group Recent Development
    Table 87. Compugen Company Detail
    Table 88. Compugen Business Overview
    Table 89. Compugen Computational Immunology Product
    Table 90. Compugen Revenue in Computational Immunology Business (2019-2024) & (US$ Million)
    Table 91. Compugen Recent Development
    Table 92. Genedata AG Company Detail
    Table 93. Genedata AG Business Overview
    Table 94. Genedata AG Computational Immunology Product
    Table 95. Genedata AG Revenue in Computational Immunology Business (2019-2024) & (US$ Million)
    Table 96. Genedata AG Recent Development
    Table 97. Insilico Biotechnology AG Company Detail
    Table 98. Insilico Biotechnology AG Business Overview
    Table 99. Insilico Biotechnology AG Computational Immunology Product
    Table 100. Insilico Biotechnology AG Revenue in Computational Immunology Business (2019-2024) & (US$ Million)
    Table 101. Insilico Biotechnology AG Recent Development
    Table 102. Leadscope Inc Company Detail
    Table 103. Leadscope Inc Business Overview
    Table 104. Leadscope Inc Computational Immunology Product
    Table 105. Leadscope Inc Revenue in Computational Immunology Business (2019-2024) & (US$ Million)
    Table 106. Leadscope Inc Recent Development
    Table 107. Nimbus Discovery Company Detail
    Table 108. Nimbus Discovery Business Overview
    Table 109. Nimbus Discovery Computational Immunology Product
    Table 110. Nimbus Discovery Revenue in Computational Immunology Business (2019-2024) & (US$ Million)
    Table 111. Nimbus Discovery Recent Development
    Table 112. Strand Life Sciences Company Detail
    Table 113. Strand Life Sciences Business Overview
    Table 114. Strand Life Sciences Computational Immunology Product
    Table 115. Strand Life Sciences Revenue in Computational Immunology Business (2019-2024) & (US$ Million)
    Table 116. Strand Life Sciences Recent Development
    Table 117. Schrodinger Company Detail
    Table 118. Schrodinger Business Overview
    Table 119. Schrodinger Computational Immunology Product
    Table 120. Schrodinger Revenue in Computational Immunology Business (2019-2024) & (US$ Million)
    Table 121. Schrodinger Recent Development
    Table 122. Simulation Plus Company Detail
    Table 123. Simulation Plus Business Overview
    Table 124. Simulation Plus Computational Immunology Product
    Table 125. Simulation Plus Revenue in Computational Immunology Business (2019-2024) & (US$ Million)
    Table 126. Simulation Plus Recent Development
    Table 127. Rosa & Co Company Detail
    Table 128. Rosa & Co Business Overview
    Table 129. Rosa & Co Computational Immunology Product
    Table 130. Rosa & Co Revenue in Computational Immunology Business (2019-2024) & (US$ Million)
    Table 131. Rosa & Co Recent Development
    Table 132. Research Programs/Design for This Report
    Table 133. Key Data Information from Secondary Sources
    Table 134. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Computational Immunology Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Computational Immunology Market Share by Type: 2023 VS 2030
    Figure 3. Cancer Diagnosis & Therapy Features
    Figure 4. Reverse Vaccinology Features
    Figure 5. Immune System Modeling Features
    Figure 6. Global Computational Immunology Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Computational Immunology Market Share by Application: 2023 VS 2030
    Figure 8. Allergy Prediction Databases Case Studies
    Figure 9. Analysis Resource Database Case Studies
    Figure 10. International Immunogenetics System Case Studies
    Figure 11. The Ontology of Immune Epitopes Case Studies
    Figure 12. Immune Epitope Database Case Studies
    Figure 13. Computational Immunology Report Years Considered
    Figure 14. Global Computational Immunology Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global Computational Immunology Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Computational Immunology Market Share by Region: 2023 VS 2030
    Figure 17. Global Computational Immunology Market Share by Players in 2023
    Figure 18. Global Top Computational Immunology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Computational Immunology as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by Computational Immunology Revenue in 2023
    Figure 20. North America Computational Immunology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America Computational Immunology Market Share by Country (2019-2030)
    Figure 22. United States Computational Immunology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada Computational Immunology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Computational Immunology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Computational Immunology Market Share by Country (2019-2030)
    Figure 26. Germany Computational Immunology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. France Computational Immunology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. U.K. Computational Immunology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Italy Computational Immunology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Russia Computational Immunology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Nordic Countries Computational Immunology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Asia-Pacific Computational Immunology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Asia-Pacific Computational Immunology Market Share by Region (2019-2030)
    Figure 34. China Computational Immunology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Japan Computational Immunology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. South Korea Computational Immunology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Southeast Asia Computational Immunology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. India Computational Immunology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Australia Computational Immunology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Latin America Computational Immunology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Latin America Computational Immunology Market Share by Country (2019-2030)
    Figure 42. Mexico Computational Immunology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Brazil Computational Immunology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Middle East & Africa Computational Immunology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Middle East & Africa Computational Immunology Market Share by Country (2019-2030)
    Figure 46. Turkey Computational Immunology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Saudi Arabia Computational Immunology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. EpiVax Revenue Growth Rate in Computational Immunology Business (2019-2024)
    Figure 49. Novozymes Biopharma Revenue Growth Rate in Computational Immunology Business (2019-2024)
    Figure 50. ioGenetics Revenue Growth Rate in Computational Immunology Business (2019-2024)
    Figure 51. International Society of Vaccines Revenue Growth Rate in Computational Immunology Business (2019-2024)
    Figure 52. IMGT Revenue Growth Rate in Computational Immunology Business (2019-2024)
    Figure 53. Dassault Systemes Revenue Growth Rate in Computational Immunology Business (2019-2024)
    Figure 54. Certara Revenue Growth Rate in Computational Immunology Business (2019-2024)
    Figure 55. Chemical Computing Group Revenue Growth Rate in Computational Immunology Business (2019-2024)
    Figure 56. Compugen Revenue Growth Rate in Computational Immunology Business (2019-2024)
    Figure 57. Genedata AG Revenue Growth Rate in Computational Immunology Business (2019-2024)
    Figure 58. Insilico Biotechnology AG Revenue Growth Rate in Computational Immunology Business (2019-2024)
    Figure 59. Leadscope Inc Revenue Growth Rate in Computational Immunology Business (2019-2024)
    Figure 60. Nimbus Discovery Revenue Growth Rate in Computational Immunology Business (2019-2024)
    Figure 61. Strand Life Sciences Revenue Growth Rate in Computational Immunology Business (2019-2024)
    Figure 62. Schrodinger Revenue Growth Rate in Computational Immunology Business (2019-2024)
    Figure 63. Simulation Plus Revenue Growth Rate in Computational Immunology Business (2019-2024)
    Figure 64. Rosa & Co Revenue Growth Rate in Computational Immunology Business (2019-2024)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS